Anastrozole

Anastrozole

Dosage
1mg
Package
56 pill 42 pill 28 pill 14 pill
Total price: 0.0
  • Anastrozole can be purchased without a prescription, with delivery available throughout the United Kingdom. Discreet and anonymous packaging is provided.
  • Anastrozole is used for the treatment of breast cancer in postmenopausal women. The drug is an aromatase inhibitor that reduces the amount of oestrogen produced in the body.
  • The usual dosage of anastrozole is 1 mg taken orally once daily.
  • The form of administration is a tablet.
  • The effect of the medication begins within 24 to 48 hours.
  • The duration of action is approximately 24 hours.
  • Limit or avoid alcohol consumption while taking anastrozole.
  • The most common side effect is hot flashes.
  • Would you like to try anastrozole without a prescription?
Trackable delivery 9-21 days
Payment method Visa, Mastercard, Discovery, AMEX, Bitcoin, Ethereum
Free delivery (by Standard Airmail) on orders over €172.19

Anastrozole

Basic Anastrozole Information

  • INN (International Nonproprietary Name): Anastrozole
  • Brand Names Available in United Kingdom: Arimidex, Anastrozole Teva, Anastrozole Sandoz
  • ATC Code: L02BG03
  • Forms & Dosages: Tablets, 1 mg
  • Manufacturers in United Kingdom: AstraZeneca, various generics
  • Registration Status in United Kingdom: Prescription only
  • OTC / Rx Classification: Rx only

Everyday Use & Best Practices

When incorporating anastrozole into daily routines, the timing of doses plays a crucial role. Many patients report a preference for taking anastrozole in the morning. This may stem from practical reasons such as aligning medication with breakfast or simply establishing a regular routine. Consistency in timing can enhance adherence to the treatment plan, which is vital for maximising therapeutic effects. Taking anastrozole in the morning is particularly beneficial for those who experience side effects, as it allows patients to manage any potential fatigue or nausea during the day when they are most active. Conversely, evening dosing might suit individuals who have more flexibility during nighttime hours or those who wish to sleep through possible discomfort. However, whatever timing is chosen, sticking to the same dose time daily is key. This helps in maintaining stable drug levels within the body, ensuring optimal effectiveness in breast cancer treatment.

Taking With or Without Meals

The way anastrozole is taken relative to meals can influence its effectiveness. In the UK, dietary habits may involve varied meal timings, often centred around breakfast, lunch, and dinner. Generally, anastrozole can be taken with or without food, which provides flexibility based on personal preference. However, some foods might impact its absorption:

  • Fatty foods: These can potentially reduce the absorption of anastrozole, so it might be prudent to avoid high-fat meals when taking the medication.
  • High-fibre foods: Consuming a high-fibre diet could also affect how well the body absorbs medications.
To better integrate the drug into daily life, consider pairing it with other routine activities, like your morning coffee or just after breakfast. This can help in remembering to take it consistently, making it easier to manage treatment without disrupting normal dietary habits. Keeping a medication diary can also be beneficial, aiding in tracking both dosages and potential side effects related to specific meals.

Safety Priorities

When considering anastrozole, a common question revolves around safety profiles and who should steer clear of this medication. The balance between effectiveness and potential risks is crucial, particularly for sensitive groups.

Who should avoid it (MHRA warnings)

Certain patient populations are strongly advised against using anastrozole. Understanding these contraindications is vital for both patients and healthcare providers. Notably:

  • Pregnancy and lactation: Anastrozole is categorised as contraindicated for pregnant women and nursing mothers. The potential risks to the fetus or infant cannot be overlooked.
  • Known hypersensitivity: Anyone with a history of allergic reactions to anastrozole or any other component in its formulation should avoid this drug.
  • Premenopausal women: The use of anastrozole is not recommended for premenopausal women who are being treated for breast cancer.

Other relative contraindications require careful monitoring, including those with severe liver or renal impairment and individuals with pre-existing ischemic heart disease. A proactive discussion with a healthcare professional is advisable to weigh potential benefits against risks.

Activities to limit (driving, work safety)

Living with a condition managed by anastrozole may necessitate some lifestyle adjustments. Safety should always come first, particularly in activities requiring heightened awareness. Here are some suggestions:

  • Driving: Given potential side effects like fatigue and dizziness, it’s essential to assess driving capabilities during treatment. If experiencing these symptoms, it may be wise to limit driving until a clearer state of mind is attained.
  • Work environment: In jobs requiring precision or safety-sensitive tasks, consider an open dialogue with an employer about any necessary accommodations. This could range from altered duties to flexible hours, ensuring safety is prioritised.

Furthermore, those affected by joint pain or weakness may need to make adjustments in lifting or carrying tasks, possibly requiring assistance or equipment that facilitates safer handling.

Dosage & Adjustments

General regimen (NHS guidance)

Those undergoing treatment for breast cancer often have many questions about how anastrozole fits into their care plan. For postmenopausal women with hormone receptor-positive breast cancer, the standard NHS guidance recommends a daily dosage of 1 mg of anastrozole. This dosage is taken orally, typically once a day.

The general treatment duration spans up to five years for adjuvant therapy, targeting early-stage breast cancer. Continuous evaluation is key; therapy may persist as long as it's beneficial in cases of advanced or metastatic breast cancer.

Special cases (elderly, comorbidities)

Adjustments in dosage may be necessary for specific patient groups, particularly the elderly and those with comorbidities such as liver or renal impairments.

  • Elderly patients: Generally, no dosage modifications are indicated, as pharmacokinetics aligns closely with those of average adults.
  • Liver impairment: For mild to moderate liver issues, no significant alterations in dosage are typically required. In cases of severe impairment, caution is advised due to limited safety data.
  • Renal impairment: Similarly, mild to moderate renal impairment does not necessitate dose adjustments. In contrast, severe renal issues require careful use.

These adjustments ensure that treatment is safe and effective, observing the balance between efficacy and potential risks for patients with existing health concerns.

Recently Viewed Products